June 18, 2019
Holland & Knight's Israel Practice Newsletter: Spring 2019
Holland & Knight invites you to read our Spring 2019 Israel Practice newsletter, in which our authors discuss pertinent American-Israeli topics. As Israel has been a crossroads and a prolific source of new ideas for more than 3,000 years, a natural tradition of inventiveness finds its most recent expression in the creation of a technology startup ecosystem with global impact. This newsletter, among other relevant topics, addresses how the innovative technologies and ideas generated in Israel can be deployed in the United States and globally.
HIGHLIGHTS:
- Financial Companies Should Review SCRA and MLA Requirements to Avoid Costly Issues
- FDA's New Pharma Shame Game
- Legal Issues and Challenges in the Cosmetics Industry
- Prospering with Pop-Ups: Legal Considerations for Landlords and Tenants
- E-2 Treaty Investor Visas Available to Israeli Nationals as of May 1, 2019
- CleanTech: Billions of Dollars Are Available Through U.S. Federal Funding Programs
- FDA Considering Changes to Regulation of CBD Products
